What does SELLAS Life Sciences Group, Inc. do?

Jun 22 2025 07:00 PM IST
share
Share Via
SELLAS Life Sciences Group, Inc. is a biopharmaceutical company focused on developing targeted oncology therapeutics. As of March 2025, it has a market cap of $155.65 million and reported a net profit loss of $6 million.
Overview:
SELLAS Life Sciences Group, Inc. is a biopharmaceutical company focused on developing and commercializing targeted oncology therapeutics in the Pharmaceuticals & Biotechnology industry.

Financial Snapshot:
Most recent Net Profit: -6 Million (Quarterly Results - Mar 2025)
Market cap: USD 155.65 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.01
Return on Equity: -97.73%
Price to Book: 5.61

Contact Details:
Address: 7 TIMES SQUARE, SUITE 2503, NEW YORK NY: 10036
Tel: 1 646 2005278
Fax: 1 925 4987799
Website: https://www.sellaslifesciences.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News